近日，清华大学药学院杨悦课题组在柳叶刀子刊《eClinicalMedicine》发表文章，题为《评估2015-2022年中国附条件批准抗肿瘤创新药上市前临床试验证据》（Evidence of pre-approval clinical trial supporting the granted conditional approval for novel cancer drugs in China betw...

识林

登录